Bogle Investment Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-19,100
| Closed | -$481K | – | 105 |
|
|
2020
Q4 | $481K | Buy |
+19,100
| New | +$481K | 0.76% | 52 |
|
|
2018
Q3 | – | Sell |
-229,253
| Closed | -$13.7M | – | 329 |
|
|
2018
Q2 | $13.7M | Buy |
229,253
+47,407
| +26% | +$2.84M | 0.99% | 20 |
|
|
2018
Q1 | $8.33M | Buy |
+181,846
| New | +$8.33M | 0.63% | 67 |
|
|
2017
Q3 | – | Sell |
-242,661
| Closed | -$10.5M | – | 345 |
|
|
2017
Q2 | $10.5M | Sell |
242,661
-117,078
| -33% | -$5.05M | 0.76% | 59 |
|
|
2017
Q1 | $11.3M | Buy |
359,739
+96,555
| +37% | +$3.02M | 0.78% | 56 |
|
|
2016
Q4 | $6.65M | Buy |
263,184
+97,673
| +59% | +$2.47M | 0.46% | 78 |
|
|
2016
Q3 | $4.09M | Buy |
+165,511
| New | +$4.09M | 0.3% | 110 |
|
|
2015
Q4 | – | Sell |
-502,319
| Closed | -$7.05M | – | 439 |
|
|
2015
Q3 | $7.05M | Hold |
502,319
| – | – | 0.5% | 79 |
|
|
2015
Q2 | $8.53M | Buy |
+502,319
| New | +$8.53M | 0.64% | 55 |
|